Search

Your search keyword '"Badenco, Nicolas"' showing total 159 results

Search Constraints

Start Over You searched for: Author "Badenco, Nicolas" Remove constraint Author: "Badenco, Nicolas"
159 results on '"Badenco, Nicolas"'

Search Results

1. Personalized screening before subcutaneous cardioverter-defibrillator implantation: Usefulness and outcomes in clinical practice—the S-ICD screening SIS prospective study

3. The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator

4. Sex Differences in Outcomes of Tetralogy of Fallot Patients With Implantable Cardioverter-Defibrillators

5. Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter-defibrillators: A propensity-matched analysis from a multicenter European registry

6. Recurrences of Atrial Fibrillation Despite Durable Pulmonary Vein Isolation: The PARTY-PVI Study

7. Subcutaneous implantable cardioverter-defibrillator and defibrillation testing: A propensity-matched pilot study

8. Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience

9. Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symptoms

12. Exclusion of Intra-Atrial Thrombus Diagnosis Using D-Dimer Assay Before Catheter Ablation of Atrial Fibrillation

14. Subcutaneous Implantable Cardioverter-Defibrillators in Patients With Congenital Heart Disease

15. Risk of electromagnetic interferences and inappropriate shocks during concomitant use of subcutaneous intracardiac cardioverter-defibrillator and HeartMate 3 assist device: A multicenter registry

18. Correlations Between Endocardial Voltage Mapping, Diagnosis, and Genetics in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy

19. Electrocardiographic findings in patients with arrhythmogenic cardiomyopathy and right bundle branch block ventricular tachycardia.

20. Electrocardiographic findings in patients with arrhythmogenic cardiomyopathy and right bundle branch block ventricular tachycardia

21. Electrocardiographic findings in patients with arrhythmogenic cardiomyopathy and right bundle branch block ventricular tachycardia

23. Electrocardiographic findings in patients with arrhythmogenic cardiomyopathy and right bundle branch block ventricular tachycardia

24. Clinical course of arrhythmogenic right ventricular cardiomyopathy with end-stage heart failure and outcome after heart transplantation

25. Inappropriate Shock Rates and Long-Term Complications due to Subcutaneous Implantable Cardioverter Defibrillators in Patients With and Without Heart Failure: Results From a Multicenter, International Registry

26. Sex Differences in Outcomes of Tetralogy of Fallot Patients With Implantable Cardioverter-Defibrillators

28. The prevalence of left and right bundle branch block morphology ventricular tachycardia amongst patients with arrhythmogenic cardiomyopathy and sustained ventricular tachycardia: insights from the European Survey on Arrhythmogenic Cardiomyopathy.

29. The prevalence of left and right bundle branch block morphology ventricular tachycardia amongst patients with arrhythmogenic cardiomyopathy and sustained ventricular tachycardia:insights from the European Survey on Arrhythmogenic Cardiomyopathy

30. The prevalence of left and right bundle branch block morphology ventricular tachycardia amongst patients with arrhythmogenic cardiomyopathy and sustained ventricular tachycardia: insights from the European Survey on Arrhythmogenic Cardiomyopathy

31. MP-470545-008 RISK OF ELECTROMAGNETIC INTERFERENCES AND INAPPROPRIATE SHOCKS DURING CONCOMITANT USE OF SUBCUTANEOUS INTRACARDIAC CARDIOVERTER-DEFIBRILLATOR AND HEARTMATE III ASSIST DEVICE: A MULTICENTER REGISTRY

32. Electrocardiographic Findings in Patients with Arrhythmogenic Cardiomyopathy and Right Bundle Branch Block Ventricular Tachycardia

33. Pre-implant predictors of inappropriate shocks with the third-generation subcutaneous implantable cardioverter defibrillator.

35. Cryoballoon ablation vs. antiarrhythmic drugs

36. The prevalence of left and right bundle branch block morphology ventricular tachycardia amongst patients with arrhythmogenic cardiomyopathy and sustained ventricular tachycardia: insights from the European Survey on Arrhythmogenic Cardiomyopathy

37. Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study

39. B-PO01-063 LATER ONSET OF FIRST SUSTAINED RBBB-VT AS COMPARED TO FIRST LBBB-VT IN PATIENTS WITH ARRHYTHMOGENIC CARDIOMYOPATHY

40. Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation:an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry

41. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial

43. Long-Term Follow-Up of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator

44. Reproducibility of pulmonary vein isolation guided by the ablation index: 1‐year outcome of the AIR registry

45. Safety and efficacy of flecainide associated with beta-blockers in arrhythmogenic right ventricular cardiomyopathy.

46. Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation.

47. Reproducibility of acute pulmonary vein isolation guided by the ablation index

48. Exclusion of Intra-Atrial Thrombus Diagnosis Using D-Dimer Assay Before Catheter Ablation of Atrial Fibrillation

50. B-PO04-170 SEX DIFFERENCES IN PATIENTS WITH ARRHYTHMOGENIC CARDIOMYOPATHY WITH RESPECT TO VENTRICULAR TACHYCARDIA MORPHOLOGY

Catalog

Books, media, physical & digital resources